nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—coronary artery disease	0.268	1	CbGaD
Amphetamine—Nateglinide—Enalapril—coronary artery disease	0.05	0.129	CrCrCtD
Amphetamine—Nateglinide—Trandolapril—coronary artery disease	0.05	0.129	CrCrCtD
Amphetamine—Aspartame—Enalapril—coronary artery disease	0.0474	0.122	CrCrCtD
Amphetamine—Aspartame—Trandolapril—coronary artery disease	0.0474	0.122	CrCrCtD
Amphetamine—SLC22A5—Niacin—coronary artery disease	0.0463	0.329	CbGbCtD
Amphetamine—Lisdexamfetamine—Lisinopril—coronary artery disease	0.0438	0.113	CrCrCtD
Amphetamine—Nateglinide—Lisinopril—coronary artery disease	0.0391	0.101	CrCrCtD
Amphetamine—Nateglinide—Ramipril—coronary artery disease	0.0379	0.0974	CrCrCtD
Amphetamine—Aspartame—Lisinopril—coronary artery disease	0.0371	0.0955	CrCrCtD
Amphetamine—Aspartame—Ramipril—coronary artery disease	0.036	0.0925	CrCrCtD
Amphetamine—SLC22A5—Furosemide—coronary artery disease	0.0305	0.216	CbGbCtD
Amphetamine—CYP2D6—Niacin—coronary artery disease	0.0111	0.0786	CbGbCtD
Amphetamine—CYP2D6—Timolol—coronary artery disease	0.0103	0.0731	CbGbCtD
Amphetamine—CYP2D6—Captopril—coronary artery disease	0.00907	0.0643	CbGbCtD
Amphetamine—CYP2D6—Simvastatin—coronary artery disease	0.00876	0.0621	CbGbCtD
Amphetamine—CYP2D6—Lovastatin—coronary artery disease	0.00857	0.0608	CbGbCtD
Amphetamine—CYP2D6—Pravastatin—coronary artery disease	0.00857	0.0608	CbGbCtD
Amphetamine—CYP2D6—Atorvastatin—coronary artery disease	0.0078	0.0554	CbGbCtD
Amphetamine—Phenformin—KCNJ8—coronary artery disease	0.000639	0.232	CrCbGaD
Amphetamine—Tolazoline—HRH2—coronary artery disease	0.000454	0.165	CrCbGaD
Amphetamine—SLC6A2—sympathetic nervous system—coronary artery disease	0.0004	0.24	CbGeAlD
Amphetamine—Lacosamide—CA5B—coronary artery disease	0.000332	0.121	CrCbGaD
Amphetamine—SLC6A2—autonomic nervous system—coronary artery disease	0.000269	0.161	CbGeAlD
Amphetamine—Benzyl alcohol—ALDH2—coronary artery disease	0.000253	0.0918	CrCbGaD
Amphetamine—CARTPT—blood—coronary artery disease	0.000202	0.121	CbGeAlD
Amphetamine—Methamphetamine—SLC22A3—coronary artery disease	0.000135	0.0491	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB1—coronary artery disease	0.000116	0.042	CrCbGaD
Amphetamine—Ephedrine—ADRB2—coronary artery disease	0.000108	0.0394	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB1—coronary artery disease	9.77e-05	0.0355	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB2—coronary artery disease	9.72e-05	0.0353	CrCbGaD
Amphetamine—Pseudoephedrine—TNF—coronary artery disease	9.27e-05	0.0337	CrCbGaD
Amphetamine—MAOB—cardiac ventricle—coronary artery disease	9.24e-05	0.0553	CbGeAlD
Amphetamine—Nateglinide—PPARG—coronary artery disease	9.1e-05	0.0331	CrCbGaD
Amphetamine—Tranylcypromine—CYP2C19—coronary artery disease	8.9e-05	0.0324	CrCbGaD
Amphetamine—Body temperature increased—Trandolapril—coronary artery disease	8.77e-05	0.000721	CcSEcCtD
Amphetamine—Abdominal pain—Trandolapril—coronary artery disease	8.77e-05	0.000721	CcSEcCtD
Amphetamine—Dizziness—Ezetimibe—coronary artery disease	8.77e-05	0.00072	CcSEcCtD
Amphetamine—Palpitations—Timolol—coronary artery disease	8.76e-05	0.00072	CcSEcCtD
Amphetamine—Abdominal pain—Enalapril—coronary artery disease	8.74e-05	0.000718	CcSEcCtD
Amphetamine—Body temperature increased—Enalapril—coronary artery disease	8.74e-05	0.000718	CcSEcCtD
Amphetamine—Insomnia—Losartan—coronary artery disease	8.73e-05	0.000717	CcSEcCtD
Amphetamine—Rash—Fenofibrate—coronary artery disease	8.73e-05	0.000717	CcSEcCtD
Amphetamine—Dermatitis—Fenofibrate—coronary artery disease	8.72e-05	0.000716	CcSEcCtD
Amphetamine—Decreased appetite—Furosemide—coronary artery disease	8.7e-05	0.000714	CcSEcCtD
Amphetamine—MAOB—myocardium—coronary artery disease	8.69e-05	0.052	CbGeAlD
Amphetamine—Headache—Fenofibrate—coronary artery disease	8.67e-05	0.000712	CcSEcCtD
Amphetamine—Gastrointestinal pain—Captopril—coronary artery disease	8.67e-05	0.000712	CcSEcCtD
Amphetamine—Urticaria—Telmisartan—coronary artery disease	8.66e-05	0.000711	CcSEcCtD
Amphetamine—Vomiting—Clopidogrel—coronary artery disease	8.65e-05	0.00071	CcSEcCtD
Amphetamine—Diarrhoea—Simvastatin—coronary artery disease	8.65e-05	0.00071	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Furosemide—coronary artery disease	8.64e-05	0.00071	CcSEcCtD
Amphetamine—Chest pain—Ramipril—coronary artery disease	8.64e-05	0.000709	CcSEcCtD
Amphetamine—Fatigue—Furosemide—coronary artery disease	8.63e-05	0.000709	CcSEcCtD
Amphetamine—Tremor—Lisinopril—coronary artery disease	8.62e-05	0.000708	CcSEcCtD
Amphetamine—Abdominal pain—Telmisartan—coronary artery disease	8.62e-05	0.000708	CcSEcCtD
Amphetamine—Body temperature increased—Telmisartan—coronary artery disease	8.62e-05	0.000708	CcSEcCtD
Amphetamine—Dyspnoea—Losartan—coronary artery disease	8.61e-05	0.000707	CcSEcCtD
Amphetamine—Anxiety—Ramipril—coronary artery disease	8.61e-05	0.000707	CcSEcCtD
Amphetamine—Vomiting—Lovastatin—coronary artery disease	8.59e-05	0.000706	CcSEcCtD
Amphetamine—Somnolence—Losartan—coronary artery disease	8.58e-05	0.000705	CcSEcCtD
Amphetamine—Dizziness—Eplerenone—coronary artery disease	8.58e-05	0.000705	CcSEcCtD
Amphetamine—Rash—Clopidogrel—coronary artery disease	8.58e-05	0.000705	CcSEcCtD
Amphetamine—Dermatitis—Clopidogrel—coronary artery disease	8.57e-05	0.000704	CcSEcCtD
Amphetamine—Asthenia—Valsartan—coronary artery disease	8.57e-05	0.000703	CcSEcCtD
Amphetamine—Hypertension—Timolol—coronary artery disease	8.56e-05	0.000703	CcSEcCtD
Amphetamine—Constipation—Furosemide—coronary artery disease	8.56e-05	0.000703	CcSEcCtD
Amphetamine—Hypersensitivity—Niacin—coronary artery disease	8.55e-05	0.000702	CcSEcCtD
Amphetamine—Asthenia—Olmesartan—coronary artery disease	8.52e-05	0.0007	CcSEcCtD
Amphetamine—Headache—Clopidogrel—coronary artery disease	8.52e-05	0.0007	CcSEcCtD
Amphetamine—Rash—Lovastatin—coronary artery disease	8.52e-05	0.0007	CcSEcCtD
Amphetamine—Dermatitis—Lovastatin—coronary artery disease	8.51e-05	0.000699	CcSEcCtD
Amphetamine—Dyspepsia—Losartan—coronary artery disease	8.5e-05	0.000698	CcSEcCtD
Amphetamine—Headache—Lovastatin—coronary artery disease	8.47e-05	0.000695	CcSEcCtD
Amphetamine—Dry mouth—Ramipril—coronary artery disease	8.45e-05	0.000694	CcSEcCtD
Amphetamine—Chest pain—Timolol—coronary artery disease	8.44e-05	0.000693	CcSEcCtD
Amphetamine—Vomiting—Ezetimibe—coronary artery disease	8.43e-05	0.000692	CcSEcCtD
Amphetamine—Hypersensitivity—Pravastatin—coronary artery disease	8.42e-05	0.000692	CcSEcCtD
Amphetamine—Gastrointestinal pain—Perindopril—coronary artery disease	8.42e-05	0.000691	CcSEcCtD
Amphetamine—Anxiety—Timolol—coronary artery disease	8.41e-05	0.000691	CcSEcCtD
Amphetamine—Angioedema—Lisinopril—coronary artery disease	8.41e-05	0.00069	CcSEcCtD
Amphetamine—Decreased appetite—Losartan—coronary artery disease	8.39e-05	0.000689	CcSEcCtD
Amphetamine—Abdominal pain—Captopril—coronary artery disease	8.38e-05	0.000688	CcSEcCtD
Amphetamine—Body temperature increased—Captopril—coronary artery disease	8.38e-05	0.000688	CcSEcCtD
Amphetamine—Dizziness—Simvastatin—coronary artery disease	8.36e-05	0.000687	CcSEcCtD
Amphetamine—Rash—Ezetimibe—coronary artery disease	8.36e-05	0.000686	CcSEcCtD
Amphetamine—Dermatitis—Ezetimibe—coronary artery disease	8.35e-05	0.000686	CcSEcCtD
Amphetamine—Asthenia—Niacin—coronary artery disease	8.33e-05	0.000684	CcSEcCtD
Amphetamine—Fatigue—Losartan—coronary artery disease	8.32e-05	0.000684	CcSEcCtD
Amphetamine—Headache—Ezetimibe—coronary artery disease	8.3e-05	0.000682	CcSEcCtD
Amphetamine—Anaphylactic shock—Ramipril—coronary artery disease	8.28e-05	0.00068	CcSEcCtD
Amphetamine—Dry mouth—Timolol—coronary artery disease	8.26e-05	0.000678	CcSEcCtD
Amphetamine—Constipation—Losartan—coronary artery disease	8.26e-05	0.000678	CcSEcCtD
Amphetamine—Vomiting—Eplerenone—coronary artery disease	8.25e-05	0.000678	CcSEcCtD
Amphetamine—Nausea—Fenofibrate—coronary artery disease	8.22e-05	0.000675	CcSEcCtD
Amphetamine—Pseudoephedrine—ADRB2—coronary artery disease	8.22e-05	0.0299	CrCbGaD
Amphetamine—Asthenia—Pravastatin—coronary artery disease	8.2e-05	0.000673	CcSEcCtD
Amphetamine—Gastrointestinal pain—Furosemide—coronary artery disease	8.18e-05	0.000672	CcSEcCtD
Amphetamine—Rash—Eplerenone—coronary artery disease	8.18e-05	0.000672	CcSEcCtD
Amphetamine—Urticaria—Perindopril—coronary artery disease	8.18e-05	0.000672	CcSEcCtD
Amphetamine—Hypersensitivity—Trandolapril—coronary artery disease	8.18e-05	0.000672	CcSEcCtD
Amphetamine—Dermatitis—Eplerenone—coronary artery disease	8.17e-05	0.000671	CcSEcCtD
Amphetamine—Diarrhoea—Valsartan—coronary artery disease	8.17e-05	0.000671	CcSEcCtD
Amphetamine—Hypersensitivity—Enalapril—coronary artery disease	8.14e-05	0.000669	CcSEcCtD
Amphetamine—Abdominal pain—Perindopril—coronary artery disease	8.14e-05	0.000668	CcSEcCtD
Amphetamine—Body temperature increased—Perindopril—coronary artery disease	8.14e-05	0.000668	CcSEcCtD
Amphetamine—Palpitations—Lisinopril—coronary artery disease	8.13e-05	0.000668	CcSEcCtD
Amphetamine—Diarrhoea—Olmesartan—coronary artery disease	8.13e-05	0.000668	CcSEcCtD
Amphetamine—Headache—Eplerenone—coronary artery disease	8.13e-05	0.000668	CcSEcCtD
Amphetamine—Anaphylactic shock—Timolol—coronary artery disease	8.09e-05	0.000665	CcSEcCtD
Amphetamine—Nausea—Clopidogrel—coronary artery disease	8.08e-05	0.000664	CcSEcCtD
Amphetamine—Tachycardia—Ramipril—coronary artery disease	8.08e-05	0.000664	CcSEcCtD
Amphetamine—Infection—Timolol—coronary artery disease	8.04e-05	0.00066	CcSEcCtD
Amphetamine—Vomiting—Simvastatin—coronary artery disease	8.04e-05	0.00066	CcSEcCtD
Amphetamine—Hypersensitivity—Telmisartan—coronary artery disease	8.03e-05	0.00066	CcSEcCtD
Amphetamine—Nausea—Lovastatin—coronary artery disease	8.03e-05	0.000659	CcSEcCtD
Amphetamine—Hyperhidrosis—Ramipril—coronary artery disease	8e-05	0.000657	CcSEcCtD
Amphetamine—Rash—Simvastatin—coronary artery disease	7.97e-05	0.000655	CcSEcCtD
Amphetamine—Dermatitis—Simvastatin—coronary artery disease	7.96e-05	0.000654	CcSEcCtD
Amphetamine—Asthenia—Trandolapril—coronary artery disease	7.96e-05	0.000654	CcSEcCtD
Amphetamine—Urticaria—Furosemide—coronary artery disease	7.95e-05	0.000653	CcSEcCtD
Amphetamine—Diarrhoea—Niacin—coronary artery disease	7.94e-05	0.000652	CcSEcCtD
Amphetamine—Asthenia—Enalapril—coronary artery disease	7.93e-05	0.000651	CcSEcCtD
Amphetamine—Headache—Simvastatin—coronary artery disease	7.92e-05	0.00065	CcSEcCtD
Amphetamine—Abdominal pain—Furosemide—coronary artery disease	7.91e-05	0.00065	CcSEcCtD
Amphetamine—Body temperature increased—Furosemide—coronary artery disease	7.91e-05	0.00065	CcSEcCtD
Amphetamine—Gastrointestinal pain—Losartan—coronary artery disease	7.9e-05	0.000648	CcSEcCtD
Amphetamine—Dizziness—Valsartan—coronary artery disease	7.89e-05	0.000648	CcSEcCtD
Amphetamine—Anorexia—Ramipril—coronary artery disease	7.89e-05	0.000648	CcSEcCtD
Amphetamine—Nausea—Ezetimibe—coronary artery disease	7.87e-05	0.000647	CcSEcCtD
Amphetamine—Dizziness—Olmesartan—coronary artery disease	7.86e-05	0.000645	CcSEcCtD
Amphetamine—Chest pain—Lisinopril—coronary artery disease	7.83e-05	0.000643	CcSEcCtD
Amphetamine—Hyperhidrosis—Timolol—coronary artery disease	7.82e-05	0.000643	CcSEcCtD
Amphetamine—Asthenia—Telmisartan—coronary artery disease	7.82e-05	0.000642	CcSEcCtD
Amphetamine—Diarrhoea—Pravastatin—coronary artery disease	7.82e-05	0.000642	CcSEcCtD
Amphetamine—Anxiety—Lisinopril—coronary artery disease	7.81e-05	0.000641	CcSEcCtD
Amphetamine—Anorexia—Timolol—coronary artery disease	7.71e-05	0.000634	CcSEcCtD
Amphetamine—Nausea—Eplerenone—coronary artery disease	7.71e-05	0.000633	CcSEcCtD
Amphetamine—Dizziness—Niacin—coronary artery disease	7.68e-05	0.00063	CcSEcCtD
Amphetamine—Urticaria—Losartan—coronary artery disease	7.67e-05	0.00063	CcSEcCtD
Amphetamine—Dry mouth—Lisinopril—coronary artery disease	7.66e-05	0.000629	CcSEcCtD
Amphetamine—Body temperature increased—Losartan—coronary artery disease	7.63e-05	0.000627	CcSEcCtD
Amphetamine—Abdominal pain—Losartan—coronary artery disease	7.63e-05	0.000627	CcSEcCtD
Amphetamine—Asthenia—Captopril—coronary artery disease	7.61e-05	0.000625	CcSEcCtD
Amphetamine—Diarrhoea—Trandolapril—coronary artery disease	7.59e-05	0.000624	CcSEcCtD
Amphetamine—Vomiting—Valsartan—coronary artery disease	7.59e-05	0.000623	CcSEcCtD
Amphetamine—Diarrhoea—Enalapril—coronary artery disease	7.56e-05	0.000621	CcSEcCtD
Amphetamine—Dizziness—Pravastatin—coronary artery disease	7.56e-05	0.000621	CcSEcCtD
Amphetamine—Vomiting—Olmesartan—coronary artery disease	7.55e-05	0.00062	CcSEcCtD
Amphetamine—Rash—Valsartan—coronary artery disease	7.53e-05	0.000618	CcSEcCtD
Amphetamine—Dermatitis—Valsartan—coronary artery disease	7.52e-05	0.000618	CcSEcCtD
Amphetamine—Nausea—Simvastatin—coronary artery disease	7.51e-05	0.000617	CcSEcCtD
Amphetamine—Anaphylactic shock—Lisinopril—coronary artery disease	7.51e-05	0.000617	CcSEcCtD
Amphetamine—Rash—Olmesartan—coronary artery disease	7.49e-05	0.000615	CcSEcCtD
Amphetamine—Insomnia—Ramipril—coronary artery disease	7.49e-05	0.000615	CcSEcCtD
Amphetamine—Dermatitis—Olmesartan—coronary artery disease	7.48e-05	0.000615	CcSEcCtD
Amphetamine—Headache—Valsartan—coronary artery disease	7.48e-05	0.000614	CcSEcCtD
Amphetamine—Diarrhoea—Telmisartan—coronary artery disease	7.46e-05	0.000613	CcSEcCtD
Amphetamine—Infection—Lisinopril—coronary artery disease	7.46e-05	0.000613	CcSEcCtD
Amphetamine—Headache—Olmesartan—coronary artery disease	7.44e-05	0.000611	CcSEcCtD
Amphetamine—Asthenia—Perindopril—coronary artery disease	7.39e-05	0.000607	CcSEcCtD
Amphetamine—Dyspnoea—Ramipril—coronary artery disease	7.38e-05	0.000606	CcSEcCtD
Amphetamine—Vomiting—Niacin—coronary artery disease	7.38e-05	0.000606	CcSEcCtD
Amphetamine—Hypersensitivity—Furosemide—coronary artery disease	7.37e-05	0.000606	CcSEcCtD
Amphetamine—Somnolence—Ramipril—coronary artery disease	7.36e-05	0.000604	CcSEcCtD
Amphetamine—Dizziness—Trandolapril—coronary artery disease	7.34e-05	0.000603	CcSEcCtD
Amphetamine—Tachycardia—Lisinopril—coronary artery disease	7.33e-05	0.000602	CcSEcCtD
Amphetamine—Insomnia—Timolol—coronary artery disease	7.32e-05	0.000601	CcSEcCtD
Amphetamine—Rash—Niacin—coronary artery disease	7.32e-05	0.000601	CcSEcCtD
Amphetamine—Dermatitis—Niacin—coronary artery disease	7.31e-05	0.000601	CcSEcCtD
Amphetamine—Dizziness—Enalapril—coronary artery disease	7.31e-05	0.0006	CcSEcCtD
Amphetamine—Dyspepsia—Ramipril—coronary artery disease	7.29e-05	0.000599	CcSEcCtD
Amphetamine—Headache—Niacin—coronary artery disease	7.27e-05	0.000597	CcSEcCtD
Amphetamine—Vomiting—Pravastatin—coronary artery disease	7.27e-05	0.000597	CcSEcCtD
Amphetamine—SLC22A5—cardiac ventricle—coronary artery disease	7.26e-05	0.0435	CbGeAlD
Amphetamine—Hyperhidrosis—Lisinopril—coronary artery disease	7.26e-05	0.000596	CcSEcCtD
Amphetamine—Diarrhoea—Captopril—coronary artery disease	7.25e-05	0.000596	CcSEcCtD
Amphetamine—Dyspnoea—Timolol—coronary artery disease	7.22e-05	0.000593	CcSEcCtD
Amphetamine—Dizziness—Telmisartan—coronary artery disease	7.21e-05	0.000592	CcSEcCtD
Amphetamine—Rash—Pravastatin—coronary artery disease	7.21e-05	0.000592	CcSEcCtD
Amphetamine—Dermatitis—Pravastatin—coronary artery disease	7.2e-05	0.000591	CcSEcCtD
Amphetamine—Decreased appetite—Ramipril—coronary artery disease	7.2e-05	0.000591	CcSEcCtD
Amphetamine—Somnolence—Timolol—coronary artery disease	7.2e-05	0.000591	CcSEcCtD
Amphetamine—Asthenia—Furosemide—coronary artery disease	7.18e-05	0.00059	CcSEcCtD
Amphetamine—Headache—Pravastatin—coronary artery disease	7.16e-05	0.000588	CcSEcCtD
Amphetamine—Anorexia—Lisinopril—coronary artery disease	7.16e-05	0.000588	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ramipril—coronary artery disease	7.15e-05	0.000587	CcSEcCtD
Amphetamine—Fatigue—Ramipril—coronary artery disease	7.14e-05	0.000586	CcSEcCtD
Amphetamine—Dyspepsia—Timolol—coronary artery disease	7.12e-05	0.000585	CcSEcCtD
Amphetamine—Hypersensitivity—Losartan—coronary artery disease	7.11e-05	0.000584	CcSEcCtD
Amphetamine—Nausea—Valsartan—coronary artery disease	7.09e-05	0.000582	CcSEcCtD
Amphetamine—Constipation—Ramipril—coronary artery disease	7.08e-05	0.000581	CcSEcCtD
Amphetamine—Nausea—Olmesartan—coronary artery disease	7.06e-05	0.00058	CcSEcCtD
Amphetamine—Vomiting—Trandolapril—coronary artery disease	7.06e-05	0.00058	CcSEcCtD
Amphetamine—Diarrhoea—Perindopril—coronary artery disease	7.04e-05	0.000578	CcSEcCtD
Amphetamine—Decreased appetite—Timolol—coronary artery disease	7.04e-05	0.000578	CcSEcCtD
Amphetamine—Vomiting—Enalapril—coronary artery disease	7.03e-05	0.000577	CcSEcCtD
Amphetamine—Dizziness—Captopril—coronary artery disease	7.01e-05	0.000576	CcSEcCtD
Amphetamine—Rash—Trandolapril—coronary artery disease	7e-05	0.000575	CcSEcCtD
Amphetamine—Dermatitis—Trandolapril—coronary artery disease	6.99e-05	0.000574	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Timolol—coronary artery disease	6.99e-05	0.000574	CcSEcCtD
Amphetamine—Fatigue—Timolol—coronary artery disease	6.98e-05	0.000573	CcSEcCtD
Amphetamine—Rash—Enalapril—coronary artery disease	6.97e-05	0.000572	CcSEcCtD
Amphetamine—Dermatitis—Enalapril—coronary artery disease	6.96e-05	0.000572	CcSEcCtD
Amphetamine—Headache—Trandolapril—coronary artery disease	6.95e-05	0.000571	CcSEcCtD
Amphetamine—Vomiting—Telmisartan—coronary artery disease	6.93e-05	0.000569	CcSEcCtD
Amphetamine—Asthenia—Losartan—coronary artery disease	6.93e-05	0.000569	CcSEcCtD
Amphetamine—Headache—Enalapril—coronary artery disease	6.92e-05	0.000569	CcSEcCtD
Amphetamine—Selegiline—CYP2C19—coronary artery disease	6.9e-05	0.0251	CrCbGaD
Amphetamine—Nausea—Niacin—coronary artery disease	6.89e-05	0.000566	CcSEcCtD
Amphetamine—Rash—Telmisartan—coronary artery disease	6.87e-05	0.000565	CcSEcCtD
Amphetamine—SLC18A2—blood—coronary artery disease	6.87e-05	0.0411	CbGeAlD
Amphetamine—Dermatitis—Telmisartan—coronary artery disease	6.87e-05	0.000564	CcSEcCtD
Amphetamine—Diarrhoea—Furosemide—coronary artery disease	6.85e-05	0.000562	CcSEcCtD
Amphetamine—Headache—Telmisartan—coronary artery disease	6.83e-05	0.000561	CcSEcCtD
Amphetamine—SLC22A5—myocardium—coronary artery disease	6.83e-05	0.0409	CbGeAlD
Amphetamine—Dizziness—Perindopril—coronary artery disease	6.81e-05	0.000559	CcSEcCtD
Amphetamine—Insomnia—Lisinopril—coronary artery disease	6.79e-05	0.000558	CcSEcCtD
Amphetamine—Nausea—Pravastatin—coronary artery disease	6.79e-05	0.000558	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ramipril—coronary artery disease	6.77e-05	0.000556	CcSEcCtD
Amphetamine—Vomiting—Captopril—coronary artery disease	6.74e-05	0.000554	CcSEcCtD
Amphetamine—Dyspnoea—Lisinopril—coronary artery disease	6.69e-05	0.00055	CcSEcCtD
Amphetamine—Rash—Captopril—coronary artery disease	6.68e-05	0.000549	CcSEcCtD
Amphetamine—Dermatitis—Captopril—coronary artery disease	6.68e-05	0.000549	CcSEcCtD
Amphetamine—Somnolence—Lisinopril—coronary artery disease	6.67e-05	0.000548	CcSEcCtD
Amphetamine—Headache—Captopril—coronary artery disease	6.64e-05	0.000545	CcSEcCtD
Amphetamine—Gastrointestinal pain—Timolol—coronary artery disease	6.62e-05	0.000544	CcSEcCtD
Amphetamine—Dizziness—Furosemide—coronary artery disease	6.62e-05	0.000543	CcSEcCtD
Amphetamine—Dyspepsia—Lisinopril—coronary artery disease	6.61e-05	0.000543	CcSEcCtD
Amphetamine—Diarrhoea—Losartan—coronary artery disease	6.61e-05	0.000543	CcSEcCtD
Amphetamine—Nausea—Trandolapril—coronary artery disease	6.59e-05	0.000541	CcSEcCtD
Amphetamine—Urticaria—Ramipril—coronary artery disease	6.58e-05	0.00054	CcSEcCtD
Amphetamine—Nausea—Enalapril—coronary artery disease	6.57e-05	0.000539	CcSEcCtD
Amphetamine—Vomiting—Perindopril—coronary artery disease	6.54e-05	0.000538	CcSEcCtD
Amphetamine—Abdominal pain—Ramipril—coronary artery disease	6.54e-05	0.000538	CcSEcCtD
Amphetamine—Body temperature increased—Ramipril—coronary artery disease	6.54e-05	0.000538	CcSEcCtD
Amphetamine—Decreased appetite—Lisinopril—coronary artery disease	6.53e-05	0.000536	CcSEcCtD
Amphetamine—Rash—Perindopril—coronary artery disease	6.49e-05	0.000533	CcSEcCtD
Amphetamine—Dermatitis—Perindopril—coronary artery disease	6.48e-05	0.000533	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.48e-05	0.000532	CcSEcCtD
Amphetamine—Nausea—Telmisartan—coronary artery disease	6.48e-05	0.000532	CcSEcCtD
Amphetamine—Fatigue—Lisinopril—coronary artery disease	6.47e-05	0.000532	CcSEcCtD
Amphetamine—Headache—Perindopril—coronary artery disease	6.45e-05	0.00053	CcSEcCtD
Amphetamine—Urticaria—Timolol—coronary artery disease	6.43e-05	0.000528	CcSEcCtD
Amphetamine—Constipation—Lisinopril—coronary artery disease	6.42e-05	0.000527	CcSEcCtD
Amphetamine—Body temperature increased—Timolol—coronary artery disease	6.4e-05	0.000525	CcSEcCtD
Amphetamine—Abdominal pain—Timolol—coronary artery disease	6.4e-05	0.000525	CcSEcCtD
Amphetamine—Dizziness—Losartan—coronary artery disease	6.38e-05	0.000524	CcSEcCtD
Amphetamine—Vomiting—Furosemide—coronary artery disease	6.36e-05	0.000523	CcSEcCtD
Amphetamine—Rash—Furosemide—coronary artery disease	6.31e-05	0.000518	CcSEcCtD
Amphetamine—Dermatitis—Furosemide—coronary artery disease	6.3e-05	0.000518	CcSEcCtD
Amphetamine—Nausea—Captopril—coronary artery disease	6.3e-05	0.000517	CcSEcCtD
Amphetamine—Headache—Furosemide—coronary artery disease	6.27e-05	0.000515	CcSEcCtD
Amphetamine—Gastrointestinal pain—Lisinopril—coronary artery disease	6.14e-05	0.000504	CcSEcCtD
Amphetamine—Vomiting—Losartan—coronary artery disease	6.14e-05	0.000504	CcSEcCtD
Amphetamine—Nausea—Perindopril—coronary artery disease	6.11e-05	0.000502	CcSEcCtD
Amphetamine—Hypersensitivity—Ramipril—coronary artery disease	6.1e-05	0.000501	CcSEcCtD
Amphetamine—Rash—Losartan—coronary artery disease	6.09e-05	0.0005	CcSEcCtD
Amphetamine—Phenelzine—CYP2C19—coronary artery disease	6.08e-05	0.0221	CrCbGaD
Amphetamine—Dermatitis—Losartan—coronary artery disease	6.08e-05	0.0005	CcSEcCtD
Amphetamine—MAOB—heart—coronary artery disease	6.07e-05	0.0363	CbGeAlD
Amphetamine—Headache—Losartan—coronary artery disease	6.05e-05	0.000497	CcSEcCtD
Amphetamine—Urticaria—Lisinopril—coronary artery disease	5.96e-05	0.00049	CcSEcCtD
Amphetamine—Hypersensitivity—Timolol—coronary artery disease	5.96e-05	0.00049	CcSEcCtD
Amphetamine—Nausea—Furosemide—coronary artery disease	5.94e-05	0.000488	CcSEcCtD
Amphetamine—Asthenia—Ramipril—coronary artery disease	5.94e-05	0.000488	CcSEcCtD
Amphetamine—Body temperature increased—Lisinopril—coronary artery disease	5.94e-05	0.000487	CcSEcCtD
Amphetamine—Abdominal pain—Lisinopril—coronary artery disease	5.94e-05	0.000487	CcSEcCtD
Amphetamine—Asthenia—Timolol—coronary artery disease	5.81e-05	0.000477	CcSEcCtD
Amphetamine—Nausea—Losartan—coronary artery disease	5.73e-05	0.000471	CcSEcCtD
Amphetamine—MAOB—cardiovascular system—coronary artery disease	5.72e-05	0.0343	CbGeAlD
Amphetamine—Diarrhoea—Ramipril—coronary artery disease	5.66e-05	0.000465	CcSEcCtD
Amphetamine—Diarrhoea—Timolol—coronary artery disease	5.54e-05	0.000455	CcSEcCtD
Amphetamine—Hypersensitivity—Lisinopril—coronary artery disease	5.53e-05	0.000454	CcSEcCtD
Amphetamine—Dizziness—Ramipril—coronary artery disease	5.47e-05	0.00045	CcSEcCtD
Amphetamine—Asthenia—Lisinopril—coronary artery disease	5.39e-05	0.000442	CcSEcCtD
Amphetamine—Dizziness—Timolol—coronary artery disease	5.35e-05	0.00044	CcSEcCtD
Amphetamine—Vomiting—Ramipril—coronary artery disease	5.26e-05	0.000432	CcSEcCtD
Amphetamine—Rash—Ramipril—coronary artery disease	5.22e-05	0.000429	CcSEcCtD
Amphetamine—Dermatitis—Ramipril—coronary artery disease	5.22e-05	0.000428	CcSEcCtD
Amphetamine—MAOB—cardiac atrium—coronary artery disease	5.19e-05	0.0311	CbGeAlD
Amphetamine—Headache—Ramipril—coronary artery disease	5.19e-05	0.000426	CcSEcCtD
Amphetamine—Vomiting—Timolol—coronary artery disease	5.15e-05	0.000423	CcSEcCtD
Amphetamine—Diarrhoea—Lisinopril—coronary artery disease	5.14e-05	0.000422	CcSEcCtD
Amphetamine—Rash—Timolol—coronary artery disease	5.1e-05	0.000419	CcSEcCtD
Amphetamine—Dermatitis—Timolol—coronary artery disease	5.1e-05	0.000419	CcSEcCtD
Amphetamine—Headache—Timolol—coronary artery disease	5.07e-05	0.000416	CcSEcCtD
Amphetamine—Dizziness—Lisinopril—coronary artery disease	4.96e-05	0.000408	CcSEcCtD
Amphetamine—Nausea—Ramipril—coronary artery disease	4.92e-05	0.000404	CcSEcCtD
Amphetamine—Nausea—Timolol—coronary artery disease	4.81e-05	0.000395	CcSEcCtD
Amphetamine—Vomiting—Lisinopril—coronary artery disease	4.77e-05	0.000392	CcSEcCtD
Amphetamine—SLC22A5—heart—coronary artery disease	4.77e-05	0.0285	CbGeAlD
Amphetamine—SLC6A4—blood—coronary artery disease	4.76e-05	0.0285	CbGeAlD
Amphetamine—Rash—Lisinopril—coronary artery disease	4.73e-05	0.000389	CcSEcCtD
Amphetamine—Dermatitis—Lisinopril—coronary artery disease	4.73e-05	0.000388	CcSEcCtD
Amphetamine—Headache—Lisinopril—coronary artery disease	4.7e-05	0.000386	CcSEcCtD
Amphetamine—MAOB—blood—coronary artery disease	4.53e-05	0.0271	CbGeAlD
Amphetamine—Nausea—Lisinopril—coronary artery disease	4.46e-05	0.000366	CcSEcCtD
Amphetamine—SLC22A5—cardiac atrium—coronary artery disease	4.08e-05	0.0244	CbGeAlD
Amphetamine—SLC22A5—blood—coronary artery disease	3.56e-05	0.0213	CbGeAlD
Amphetamine—Nateglinide—ALB—coronary artery disease	3.42e-05	0.0124	CrCbGaD
Amphetamine—CYP2D6—blood—coronary artery disease	2.3e-05	0.0137	CbGeAlD
Amphetamine—DRD2—Signaling by GPCR—PRKCE—coronary artery disease	5.36e-06	7.08e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—EDN1—coronary artery disease	5.35e-06	7.06e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—coronary artery disease	5.3e-06	7.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPP3R1—coronary artery disease	5.3e-06	7e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKR1B1—coronary artery disease	5.28e-06	6.98e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HK2—coronary artery disease	5.28e-06	6.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADM—coronary artery disease	5.25e-06	6.93e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CSF2—coronary artery disease	5.22e-06	6.9e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—coronary artery disease	5.19e-06	6.85e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AGT—coronary artery disease	5.14e-06	6.79e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—coronary artery disease	5.12e-06	6.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDE4B—coronary artery disease	5.12e-06	6.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBB—coronary artery disease	5.12e-06	6.76e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—coronary artery disease	5.11e-06	6.75e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMB5—coronary artery disease	5.11e-06	6.75e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMA6—coronary artery disease	5.11e-06	6.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MMP3—coronary artery disease	5.1e-06	6.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC27A1—coronary artery disease	5.06e-06	6.69e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—coronary artery disease	5.04e-06	6.66e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CTGF—coronary artery disease	4.99e-06	6.6e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOA1—coronary artery disease	4.98e-06	6.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1B—coronary artery disease	4.97e-06	6.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LCAT—coronary artery disease	4.97e-06	6.56e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—coronary artery disease	4.95e-06	6.54e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMGCR—coronary artery disease	4.95e-06	6.54e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—coronary artery disease	4.95e-06	6.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA4—coronary artery disease	4.88e-06	6.44e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK1—coronary artery disease	4.86e-06	6.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EDN1—coronary artery disease	4.85e-06	6.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—coronary artery disease	4.82e-06	6.36e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCD—coronary artery disease	4.78e-06	6.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CSF2—coronary artery disease	4.74e-06	6.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PDHA1—coronary artery disease	4.71e-06	6.22e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCLM—coronary artery disease	4.71e-06	6.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR3—coronary artery disease	4.68e-06	6.18e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—coronary artery disease	4.68e-06	6.18e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—C3—coronary artery disease	4.67e-06	6.17e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—coronary artery disease	4.66e-06	6.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRK—coronary artery disease	4.62e-06	6.1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP11B2—coronary artery disease	4.56e-06	6.02e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TXNRD1—coronary artery disease	4.56e-06	6.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SH2B3—coronary artery disease	4.56e-06	6.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ATP2A2—coronary artery disease	4.56e-06	6.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VWF—coronary artery disease	4.56e-06	6.02e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLCB1—coronary artery disease	4.55e-06	6.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOC3—coronary artery disease	4.53e-06	5.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LDLR—coronary artery disease	4.5e-06	5.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC22A3—coronary artery disease	4.49e-06	5.93e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—coronary artery disease	4.46e-06	5.89e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGT—coronary artery disease	4.44e-06	5.86e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ARNTL—coronary artery disease	4.43e-06	5.85e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HADH—coronary artery disease	4.43e-06	5.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PPP2CA—coronary artery disease	4.42e-06	5.84e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCA1—coronary artery disease	4.41e-06	5.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL2—coronary artery disease	4.4e-06	5.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL3—coronary artery disease	4.4e-06	5.81e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—coronary artery disease	4.39e-06	5.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2R—coronary artery disease	4.35e-06	5.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SDC1—coronary artery disease	4.35e-06	5.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCD—coronary artery disease	4.34e-06	5.73e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—coronary artery disease	4.33e-06	5.72e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—coronary artery disease	4.27e-06	5.64e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—coronary artery disease	4.27e-06	5.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGB—coronary artery disease	4.26e-06	5.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—coronary artery disease	4.25e-06	5.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—C3—coronary artery disease	4.24e-06	5.6e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—coronary artery disease	4.22e-06	5.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRB—coronary artery disease	4.21e-06	5.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX2—coronary artery disease	4.2e-06	5.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	4.2e-06	5.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA2—coronary artery disease	4.2e-06	5.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—THBS1—coronary artery disease	4.15e-06	5.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	4.15e-06	5.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HK1—coronary artery disease	4.15e-06	5.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG5—coronary artery disease	4.15e-06	5.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX4—coronary artery disease	4.15e-06	5.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMA6—coronary artery disease	4.11e-06	5.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMB5—coronary artery disease	4.11e-06	5.43e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—coronary artery disease	4.1e-06	5.42e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HADHA—coronary artery disease	4.1e-06	5.41e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—coronary artery disease	4.08e-06	5.39e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA1—coronary artery disease	4.05e-06	5.35e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—coronary artery disease	4.03e-06	5.32e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPA—coronary artery disease	4e-06	5.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRA—coronary artery disease	3.98e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBA—coronary artery disease	3.96e-06	5.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB1—coronary artery disease	3.96e-06	5.23e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—coronary artery disease	3.95e-06	5.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DUSP6—coronary artery disease	3.94e-06	5.21e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLCB3—coronary artery disease	3.88e-06	5.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLAT—coronary artery disease	3.88e-06	5.12e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA5—coronary artery disease	3.84e-06	5.07e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—coronary artery disease	3.84e-06	5.07e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARGC1A—coronary artery disease	3.8e-06	5.02e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—coronary artery disease	3.78e-06	5e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—coronary artery disease	3.77e-06	4.99e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—P4HB—coronary artery disease	3.76e-06	4.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB2—coronary artery disease	3.74e-06	4.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL12—coronary artery disease	3.74e-06	4.94e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—coronary artery disease	3.73e-06	4.93e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—coronary artery disease	3.73e-06	4.93e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—coronary artery disease	3.73e-06	4.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—coronary artery disease	3.72e-06	4.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6ST—coronary artery disease	3.71e-06	4.9e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	3.69e-06	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUNB—coronary artery disease	3.67e-06	4.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLCB1—coronary artery disease	3.66e-06	4.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOB—coronary artery disease	3.62e-06	4.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR7—coronary artery disease	3.58e-06	4.73e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—coronary artery disease	3.53e-06	4.66e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—VCAN—coronary artery disease	3.48e-06	4.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—coronary artery disease	3.46e-06	4.57e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDOA—coronary artery disease	3.46e-06	4.56e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—coronary artery disease	3.45e-06	4.56e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—coronary artery disease	3.44e-06	4.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITGAV—coronary artery disease	3.41e-06	4.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KNG1—coronary artery disease	3.4e-06	4.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—coronary artery disease	3.39e-06	4.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CREB1—coronary artery disease	3.39e-06	4.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR1—coronary artery disease	3.38e-06	4.47e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—coronary artery disease	3.38e-06	4.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DCN—coronary artery disease	3.35e-06	4.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—coronary artery disease	3.32e-06	4.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6R—coronary artery disease	3.31e-06	4.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL10—coronary artery disease	3.31e-06	4.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLG—coronary artery disease	3.3e-06	4.35e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD36—coronary artery disease	3.29e-06	4.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.26e-06	4.31e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPP2CA—coronary artery disease	3.25e-06	4.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—coronary artery disease	3.21e-06	4.24e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LIPC—coronary artery disease	3.18e-06	4.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HBA1—coronary artery disease	3.18e-06	4.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.18e-06	4.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.18e-06	4.2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCE—coronary artery disease	3.17e-06	4.18e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	3.17e-06	4.18e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOC3—coronary artery disease	3.16e-06	4.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOCS1—coronary artery disease	3.16e-06	4.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—S100B—coronary artery disease	3.15e-06	4.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LDLR—coronary artery disease	3.14e-06	4.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOCS3—coronary artery disease	3.12e-06	4.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—coronary artery disease	3.12e-06	4.12e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.1e-06	4.1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.1e-06	4.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KITLG—coronary artery disease	3.08e-06	4.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	3.08e-06	4.07e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CETP—coronary artery disease	3.07e-06	4.05e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCLC—coronary artery disease	3.07e-06	4.05e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SDC1—coronary artery disease	3.03e-06	4.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT5A—coronary artery disease	3.01e-06	3.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP3—coronary artery disease	3.01e-06	3.98e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—coronary artery disease	2.96e-06	3.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOB—coronary artery disease	2.91e-06	3.85e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—coronary artery disease	2.9e-06	3.83e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	2.89e-06	3.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—JAK2—coronary artery disease	2.87e-06	3.8e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA1—coronary artery disease	2.87e-06	3.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDN1—coronary artery disease	2.87e-06	3.79e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.87e-06	3.79e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.87e-06	3.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—coronary artery disease	2.85e-06	3.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CSF2—coronary artery disease	2.8e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF1—coronary artery disease	2.8e-06	3.7e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CTGF—coronary artery disease	2.8e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—coronary artery disease	2.78e-06	3.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.78e-06	3.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—coronary artery disease	2.78e-06	3.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MEF2C—coronary artery disease	2.76e-06	3.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	2.76e-06	3.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITGB3—coronary artery disease	2.69e-06	3.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	2.62e-06	3.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	2.61e-06	3.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCD—coronary artery disease	2.56e-06	3.39e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.55e-06	3.37e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—coronary artery disease	2.53e-06	3.34e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—coronary artery disease	2.51e-06	3.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—coronary artery disease	2.51e-06	3.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—C3—coronary artery disease	2.5e-06	3.31e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—coronary artery disease	2.49e-06	3.29e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.47e-06	3.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—coronary artery disease	2.4e-06	3.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—coronary artery disease	2.4e-06	3.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—coronary artery disease	2.39e-06	3.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—coronary artery disease	2.38e-06	3.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—coronary artery disease	2.33e-06	3.08e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—coronary artery disease	2.33e-06	3.08e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOA1—coronary artery disease	2.31e-06	3.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—coronary artery disease	2.28e-06	3.02e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—coronary artery disease	2.27e-06	3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK14—coronary artery disease	2.27e-06	3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—coronary artery disease	2.23e-06	2.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FN1—coronary artery disease	2.2e-06	2.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—coronary artery disease	2.2e-06	2.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6ST—coronary artery disease	2.19e-06	2.89e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—coronary artery disease	2.17e-06	2.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	2.17e-06	2.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.15e-06	2.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.13e-06	2.82e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—coronary artery disease	2.12e-06	2.81e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.12e-06	2.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KIT—coronary artery disease	2.1e-06	2.78e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—coronary artery disease	2.09e-06	2.77e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—coronary artery disease	2.05e-06	2.71e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOB—coronary artery disease	2.03e-06	2.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GSK3B—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—coronary artery disease	2e-06	2.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CREB1—coronary artery disease	2e-06	2.65e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—coronary artery disease	1.99e-06	2.63e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.98e-06	2.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—coronary artery disease	1.96e-06	2.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6R—coronary artery disease	1.95e-06	2.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—coronary artery disease	1.94e-06	2.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.93e-06	2.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.92e-06	2.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.89e-06	2.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD36—coronary artery disease	1.84e-06	2.44e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.83e-06	2.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.83e-06	2.42e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.82e-06	2.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.77e-06	2.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.75e-06	2.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.75e-06	2.31e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—coronary artery disease	1.74e-06	2.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.7e-06	2.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.66e-06	2.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—coronary artery disease	1.66e-06	2.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—coronary artery disease	1.63e-06	2.15e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.61e-06	2.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.55e-06	2.05e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.5e-06	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.48e-06	1.96e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.47e-06	1.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.44e-06	1.91e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.42e-06	1.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.4e-06	1.85e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—coronary artery disease	1.4e-06	1.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.36e-06	1.8e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—coronary artery disease	1.27e-06	1.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.26e-06	1.66e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—coronary artery disease	1.22e-06	1.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.22e-06	1.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.16e-06	1.53e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.13e-06	1.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.11e-06	1.47e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—coronary artery disease	9.99e-07	1.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	9.83e-07	1.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—coronary artery disease	8.71e-07	1.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—coronary artery disease	8.03e-07	1.06e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.86e-07	9.06e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—coronary artery disease	5.6e-07	7.4e-06	CbGpPWpGaD
